Rosetta Genomics Ltd
OTC:ROSGQ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Rosetta Genomics Ltd
Rosetta Genomics Ltd
Total Current Liabilities
Rosetta Genomics Ltd
Total Current Liabilities Peer Comparison
CLGN
KMDA
URGN
ENTX
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Total Current Liabilities
$3.8m
|
CAGR 3-Years
25%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Current Liabilities
$3.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Current Liabilities
$37.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
11%
|
CAGR 10-Years
1%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Current Liabilities
$26.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Current Liabilities
$1.1m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Current Liabilities
₪5.9m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
13%
|
See Also
What is Rosetta Genomics Ltd's Total Current Liabilities?
Total Current Liabilities
3.8m
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Total Current Liabilities amounts to 3.8m USD.
What is Rosetta Genomics Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
16%
Over the last year, the Total Current Liabilities growth was 36%. The average annual Total Current Liabilities growth rates for Rosetta Genomics Ltd have been 25% over the past three years , 16% over the past five years .
You don't have any saved screeners yet
